Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S1 from The CD94/NKG2A–HLA-E Axis as a Target in Cancer Immunotherapy: A Critical Perspective
  1. Home
  2. Publications
  3. Supplementary Table S1 from The CD94/NKG2A–HLA-E Axis as a Target in Cancer Immunotherapy: A Critical Perspective

Supplementary Table S1 from The CD94/NKG2A–HLA-E Axis as a Target in Cancer Immunotherapy: A Critical Perspective

Authors:
  • MLMiguel López-Botet
    Miguel López-Botet
  • CVCarlos Vilches
    Carlos Vilches
  • AMAura Muntasell
    Aura Muntasell

Open Access
Publisher website
Google Scholar
  • 16 March 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.31744875
Abstract
Summary of selected clinical trials assessing the safety/clinical efficacy of targeting NKG2A
Keywords
  • HLA-E AXIS
  • CANCER IMMUNOTHERAPY
  • SUPPLEMENTARY TABLE
  • CRITICAL PERSPECTIVE
  • PERSPECTIVE SUMMARY
  • TRIALS ASSESSING
  • SELECTED CLINICAL
  • CLINICAL TRIALS
  • CLINICAL EFFICACY
  • TABLE
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.